Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy

Megu Yamaguchi Baden,Akihisa Imagawa,Norio Abiru,Takuya Awata,Hiroshi Ikegami,Yasuko Uchigata,Yoichi Oikawa,Haruhiko Osawa,Hiroshi Kajio,Eiji Kawasaki,Yumiko Kawabata,Junji Kozawa,Akira Shimada,Kazuma Takahashi,Shoichiro Tanaka,Daisuke Chujo,Tomoyasu Fukui,Junnosuke Miura,Kazuki Yasuda,Hisafumi Yasuda,Tetsuro Kobayashi,Toshiaki Hanafusa

Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy

2019

Aims We conducted a national survey to clarify the characteristics and clinical course of type 1 diabetes related to anti-programmed cell death-1 therapy.

Keywords:

Nivolumab
Type 1 diabetes
Programmed cell death 1
Pembrolizumab
Cancer research
Medicine
Diabetes mellitus
Internal medicine
Urinary system
Gastroenterology
Fulminant
Diabetic ketoacidosis
Ketosis
Quartile

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations